Position in BMY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$52,779
-$6,961 QoQ
Shares Held
916
-7.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2,320
of 2,506 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026REAP Financial Group, LLC holds $2,655,040 across 8 Drug Manufacturers - General names. BMY ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,097 | $786,545 | |
| 2 | LLY |
ELI LILLY & Co
|
502 | $602,113 | |
| 3 | ABBV |
AbbVie Inc.
|
2,018 | $507,809 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,341 | $300,818 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,239 | $156,535 | |
| 6 | PFE |
Pfizer Inc
|
6,242 | $150,307 | |
| 7 | AMGN |
Amgen Inc
|
271 | $98,134 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
916 | $52,779 |
All Filings in BMY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,779 | 916 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $59,740 | 985 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $47,413 | 879 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $31,434 | 697 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $29,579 | 639 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $12,868 | 211 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,879 | 157 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $569 | 11 | Shares | Sole | 2025-02-27 | |
| 2024-06-30 | $456 | 11 | Shares | Sole | 2025-02-27 | |
| 2024-03-31 | $8,242 | 152 | Shares | Sole | 2025-02-27 | |
| 2023-12-31 | $564 | 11 | Shares | Sole | 2025-02-27 | |
| No filing history on record for this holder in this stock. | ||||||